Similar Articles
361 Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
362 Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
363 Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma
364 Treatment of recurrent hepatocellular carcinoma following liver resection, ablation or liver transplantation
365 Prognostic role of ring finger and WD repeat domain 3 and immune cell infiltration in hepatocellular carcinoma
366 Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion
367 Application of ablative therapy for intrahepatic recurrent hepatocellular carcinoma following hepatectomy
368 Impact of body mass index in elderly patients treated with laparoscopic liver resection for hepatocellular carcinoma
369 Perivascular epithelioid cell tumors of the liver misdiagnosed as hepatocellular carcinoma: Three case reports
370 Rs3746444 T>C locus in miR-499 increases the susceptibility to hepatocellular carcinoma: A meta-analysis 14812 subjects
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA